Wednesday February 10 2010 |
Biotechnology feed
|
All feeds
Home
Marketing Services
Antibodies
Careers
Directories
Drugs
Events
Genes
InDepth
News
Reports
Videos
A-Z
Business
Health
Drugs
Sources
Americas
Europe
Asia
Cancer
Cardio-
Diabetes
Bird Flu
Swine Flu
Summaries
Post News
Search
BioNews - BioPortfolio's News Portal
Drug Development News and Headlines
Sign-up to BioPortfolio's
Drug Development news alerts
.
Subscribe to
Drug RSS feed
-
-
View full RSS Index
Subscribe to
BioWatch News Email alerts
-
open
BioWatch PDF brochure
.
Publish your news
using BioNewsCast
- open
BioNewsCast PDF brochure
.
Theravance said FDA seeks more data for second indication for its drug Vibativ
NW32.com:
similar ...
News from Peregrine Pharmaceuticals highlights the most recent developments
Health & Medicine Week via NewsRx.com:
similar ...
Incyte Cites Encouraging Clinical Data in Multiple Programs; Announces Second Quarter 2007 Financial Results
Business Wire:
similar ...
Daily HIV/Aids Report
Kaisernetwork.org. Distributed by AllAfrica Global Media (allAfrica.com).:
similar ...
Progenics Presents Additional Positive Clinical Results for HIV-Entry Inhibitor PRO 140 at International AIDS Meeting
Business Wire:
similar ...
Positive Opinion for Expanded Label of CUBICIN Received from European Regulatory Authority; Decision Expected This September
Business Wire:
similar ...
, an Investigational Oral HIV Integrase Inhibitor, in Combination Therapy Demonstrated HIV RNA Reduction Comparable to Efavirenz in Treatment-Naive HIV-Positive Patients
Business Wire:
similar ...
BioCryst Initiates Phase II Clinical Trial to Evaluate Intravenous Peramivir in Patients Hospitalized With Influenza
PR Newswire:
similar ...
Presented At International AIDS Society Meeting in Sydney
Business Wire:
similar ...
Pro-Pharmaceuticals Enters Research Agreement with Global Bio-pharmaceutical Company
Business Wire:
similar ...
New Interim Results Demonstrate High Response Rate With FUZEON(R) Plus Darunavir Regardless of Existing Protease Inhibitor Resistance
PR Newswire:
similar ...
DOR BioPharma, Inc. Announces 3 Month Extension of FDA PDUFA Action Date for orBec(R) New Drug Application to Review Supplemental Data
Market Wire, Incorporated:
similar ...
Genentech officials describe the recent activities
Health & Medicine Week via NewsRx.com:
similar ...
New Phase 3 Study Published in the Lancet Evaluates Efficacy and Safety of PREZISTA/ritonavir vs. Kaletra As Part of HIV Combination Therapy in...
Drug Week via NewsRx.com:
similar ...
Switzerland healthcare: Roche's RNAi revolution
Economist Intelligence Unit:
similar ...
Geron Corporation officials report on new developments
Health & Medicine Week via NewsRx.com:
similar ...
MIGENIX Reports Fourth Quarter and Fiscal Year 2007 Financial Results
Canada Newswire Ltd. All Rights Reserved.:
similar ...
DOR BioPharma, Inc. Announces Initiation of orBec(R) Phase 2 GVHD Prophylaxis Clinical Trial
Market Wire, Incorporated:
similar ...
Mpex Pharmaceuticals Initiates Multi-Dose Clinical Trial in the U.S. with MP-376 in Patients with Cystic Fibrosis
PR Newswire:
similar ...
U.S. FDA and European EMEA Accept Registration Applications for Ceftobiprole, Novel Anti-MRSA Broad-Spectrum Cephalosporin
Market Wire, Incorporated:
similar ...
